FOR HEALTH PROFESSIONALS

New Directions for Treatment in ALS (Powerpoint slide show) (last update 6/8/06)

Robert G. Miller, M.D.            California Pacific Medical Center

Instructions for completing the Functional Rating Scale (ALSFRS-R) on the 'Health Care Professionals' Form

Neurocognitive, Behavioral and Psychological Changes Associated With ALS (PDF) (last update 12/2005)

Susan Woolley-Levine, PhD             California Pacific Medical Center

PALS have special requirements for wheelchairs that originate in the nature of the disease and its disabling effects. In the article below Joan Bales, a registered and licensed Occupational Therapist was interviewed by Dina Scholtz, MD, concerning what wheelchair PALS should choose.

Wheelchair Needs of the Person With ALS (PDF) (last update 12/2005)

Joan Bales OTR/L and Dina Scholtz, MD             California Pacific Medical Center

ALS practice parameters
(“Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force.”)

Below is an abstract and lay summary about Riluzole effects. Dr. Robert Miller and co-authors conducted an extensive literature search, compared and summarized the results.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)  (excerpt)

Miller RG, Mitchell JD, Lyon M, Moore DH         (Date edited: 08/21/2006)

If you have any questions about the ALSCONNECTION, please contact:
Stacey Championat (415)600-5764 or
Giovanna Kushner at 415-600-3938